Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Respir Physiol Neurobiol. 2017 Dec 9;256:21–28. doi: 10.1016/j.resp.2017.12.004

Figure 3.

Figure 3

Acute hypoxic ventilatory responses are unaltered by the COX-2 inhibitor (NS-398) given systemically (A) or spinally (B). Systemic NS-398 (3 mg/kg, i.p.) group data (A) demonstrate no significant effect on the hypoxic response. Similarly, intrathecal NS-398 (27 mM) group data (B) show no significant effect on the hypoxic response.